Skip to main content

Table 1 VHL peptides used for vaccinations (corresponding mutant part of peptide underlined)

From: A pilot clinical trial testing mutant von Hippel-Lindau peptide as a novel immune therapy in metastatic Renal Cell Carcinoma

Patient Mutant VHL peptide
1 YHTASVYSERAM
2 CLQVARSLVK
3 PGTGRRIHIYRGHLWL
4 RRIHSYRGDLWLFRDA
5 MEAGRPRPCCAR
6 RLALQRCRDTRWA